StockData
Abbott Laboratories logo

Abbott Laboratories (ABT) stock

ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 14/3034% above fair value
$104.71−2.74 (-2.55%)

Close on Nov 17, 2026Market cap $181.19BP/E 33.7Yield 2.29%

Abbott Laboratories market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Abbott Laboratories's market cap was $190.82B on Nov 11, 2026, against $225.29B a year earlier. Over the last 5 years it ranged from $149.62B to $252.07B, with a median of $194.87B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$190.82B-12.9%
2025Dec 31, 2025$218.98B+10.7%
2024Dec 31, 2024$197.78B+2.6%
2023Dec 29, 2023$192.70B-0.9%
2022Dec 30, 2022$194.49B-22.8%
2021Dec 31, 2021$252.07B+29.1%
2020Dec 31, 2020$195.30B+26.4%
2019Dec 31, 2019$154.52B+21.0%
2018Dec 31, 2018$127.72B+33.2%
2017Dec 29, 2017$95.91B+68.2%
2016Dec 30, 2016$57.01B-16.0%
2015Dec 31, 2015$67.89B-1.9%
2014Dec 31, 2014$69.23B+14.2%
2013Dec 31, 2013$60.60B-41.7%
2012Dec 31, 2012$103.95B+18.3%
2011Dec 30, 2011$87.85B+17.8%
2010Dec 31, 2010$74.59B-11.2%
2009Dec 31, 2009$84.00B–

More Abbott Laboratories figures

See a number that looks wrong?